Cargando…
Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke
BACKGROUND AND PURPOSE: The role of autophagy in response to ischemic stroke has been confusing with reports that both enhancement and inhibition of autophagy decrease infarct size and improve post-stroke outcomes. We sought to clarify this by comparing pharmacologic modulation of autophagy in two c...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079187/ https://www.ncbi.nlm.nih.gov/pubmed/24991402 http://dx.doi.org/10.1186/2040-7378-6-8 |
_version_ | 1782323821503578112 |
---|---|
author | Buckley, Kathleen M Hess, Daniel L Sazonova, Irina Y Periyasamy-Thandavan, Sudharsan Barrett, John R Kirks, Russell Grace, Harrison Kondrikova, Galina Johnson, Maribeth H Hess, David C Schoenlein, Patricia V Hoda, Md Nasrul Hill, William D |
author_facet | Buckley, Kathleen M Hess, Daniel L Sazonova, Irina Y Periyasamy-Thandavan, Sudharsan Barrett, John R Kirks, Russell Grace, Harrison Kondrikova, Galina Johnson, Maribeth H Hess, David C Schoenlein, Patricia V Hoda, Md Nasrul Hill, William D |
author_sort | Buckley, Kathleen M |
collection | PubMed |
description | BACKGROUND AND PURPOSE: The role of autophagy in response to ischemic stroke has been confusing with reports that both enhancement and inhibition of autophagy decrease infarct size and improve post-stroke outcomes. We sought to clarify this by comparing pharmacologic modulation of autophagy in two clinically relevant murine models of stroke. METHODS: We used rapamycin to induce autophagy, and chloroquine to block completion of autophagy, by treating mice immediately after stroke and at 24 hours post-stroke in two different models; permanent Middle Cerebral Artery Ligation (MCAL), which does not allow for reperfusion of distal trunk of middle cerebral artery, and Embolic Clot Middle Cerebral Artery Occlusion (eMCAO) which allows for a slow reperfusion similar to that seen in most human stroke patients. Outcome measures at 48 hours post-stroke included infarct size analysis, behavioral assessment using Bederson neurological scoring, and survival. RESULTS: Chloroquine treatment reduced the lesion size by approximately 30% and was significant only in the eMCAO model, where it also improved the neurological score, but did not increase survival. Rapamycin reduced lesion size by 44% and 50% in the MCAL and eMCAO models, respectively. Rapamycin also improved the neurological score to a greater degree than chloroquine and improved survival. CONCLUSIONS: While both inhibition and enhancement of autophagy by pharmacological intervention decreased lesion size and improved neurological scores, the enhancement with rapamycin showed a greater degree of improvement in outcomes as well as in survival. The protective action seen with chloroquine may be in part due to off-target effects on apoptosis separate from blocking lysosomal activity in autophagy. We conclude pharmacologic induction of autophagy is more advantageous than its blockade in physiologically-relevant permanent and slow reperfusion stroke models. |
format | Online Article Text |
id | pubmed-4079187 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40791872014-07-03 Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke Buckley, Kathleen M Hess, Daniel L Sazonova, Irina Y Periyasamy-Thandavan, Sudharsan Barrett, John R Kirks, Russell Grace, Harrison Kondrikova, Galina Johnson, Maribeth H Hess, David C Schoenlein, Patricia V Hoda, Md Nasrul Hill, William D Exp Transl Stroke Med Research BACKGROUND AND PURPOSE: The role of autophagy in response to ischemic stroke has been confusing with reports that both enhancement and inhibition of autophagy decrease infarct size and improve post-stroke outcomes. We sought to clarify this by comparing pharmacologic modulation of autophagy in two clinically relevant murine models of stroke. METHODS: We used rapamycin to induce autophagy, and chloroquine to block completion of autophagy, by treating mice immediately after stroke and at 24 hours post-stroke in two different models; permanent Middle Cerebral Artery Ligation (MCAL), which does not allow for reperfusion of distal trunk of middle cerebral artery, and Embolic Clot Middle Cerebral Artery Occlusion (eMCAO) which allows for a slow reperfusion similar to that seen in most human stroke patients. Outcome measures at 48 hours post-stroke included infarct size analysis, behavioral assessment using Bederson neurological scoring, and survival. RESULTS: Chloroquine treatment reduced the lesion size by approximately 30% and was significant only in the eMCAO model, where it also improved the neurological score, but did not increase survival. Rapamycin reduced lesion size by 44% and 50% in the MCAL and eMCAO models, respectively. Rapamycin also improved the neurological score to a greater degree than chloroquine and improved survival. CONCLUSIONS: While both inhibition and enhancement of autophagy by pharmacological intervention decreased lesion size and improved neurological scores, the enhancement with rapamycin showed a greater degree of improvement in outcomes as well as in survival. The protective action seen with chloroquine may be in part due to off-target effects on apoptosis separate from blocking lysosomal activity in autophagy. We conclude pharmacologic induction of autophagy is more advantageous than its blockade in physiologically-relevant permanent and slow reperfusion stroke models. BioMed Central 2014-06-21 /pmc/articles/PMC4079187/ /pubmed/24991402 http://dx.doi.org/10.1186/2040-7378-6-8 Text en Copyright © 2014 Buckley et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Research Buckley, Kathleen M Hess, Daniel L Sazonova, Irina Y Periyasamy-Thandavan, Sudharsan Barrett, John R Kirks, Russell Grace, Harrison Kondrikova, Galina Johnson, Maribeth H Hess, David C Schoenlein, Patricia V Hoda, Md Nasrul Hill, William D Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke |
title | Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke |
title_full | Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke |
title_fullStr | Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke |
title_full_unstemmed | Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke |
title_short | Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke |
title_sort | rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent mcal, and embolic mcao, murine models of stroke |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079187/ https://www.ncbi.nlm.nih.gov/pubmed/24991402 http://dx.doi.org/10.1186/2040-7378-6-8 |
work_keys_str_mv | AT buckleykathleenm rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke AT hessdaniell rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke AT sazonovairinay rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke AT periyasamythandavansudharsan rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke AT barrettjohnr rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke AT kirksrussell rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke AT graceharrison rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke AT kondrikovagalina rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke AT johnsonmaribethh rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke AT hessdavidc rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke AT schoenleinpatriciav rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke AT hodamdnasrul rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke AT hillwilliamd rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke |